According to Fortune Business Insights, the global peptide synthesis market size was valued at USD 746.7 million in 2025 and is projected to grow from USD 800.16 million in 2026 to USD 1,640.52 million by 2034, exhibiting a CAGR of 9.39% during the forecast period. North America dominated the peptide synthesis market with a market share of 48.59% in 2025.
The market is gaining momentum as peptides become increasingly important in pharmaceutical research, drug development, biotechnology, and the development of targeted therapies. Peptide synthesis enables researchers to create specific sequences of amino acids for applications involving therapeutic compounds, diagnostic tools, vaccines, and laboratory research. Growing interest in peptide-based medicines and advances in synthesis technologies are supporting the adoption of these solutions across the life sciences industry.
Peptide synthesis involves the chemical or biological production of peptides by connecting amino acids in a predetermined sequence. These synthesized molecules are widely used to investigate biological processes, develop therapeutic candidates, and improve the understanding of diseases. Pharmaceutical companies, biotechnology firms, academic institutions, and contract research organizations rely on peptide synthesis to support their research and development activities. The increasing focus on precision medicine and biologics is encouraging researchers to explore peptide-based approaches for addressing complex medical conditions. As research requirements become more specialized, demand for reliable synthesis technologies and high-quality peptides continues to expand.
Continue reading for more details:
https://www.fortunebusinessinsights.com/peptide-synthesis-market-114373
The peptide synthesis market can be segmented by product, technology, application, end user, and geography. Product categories include reagents, equipment, and peptide synthesis services. Reagents play an essential role in chemical reactions, amino acid coupling, purification, and the preparation of high-quality peptide sequences. Specialized equipment supports automated synthesis and improves consistency across laboratory workflows. Peptide synthesis services are also important for organizations that prefer to outsource specialized manufacturing or research activities instead of maintaining dedicated in-house infrastructure.
Based on technology, the market includes solid-phase peptide synthesis, liquid-phase peptide synthesis, and hybrid approaches. Solid-phase peptide synthesis is widely used because it allows amino acids to be added sequentially while the growing peptide remains attached to a solid support. This method can simplify purification and support the production of complex sequences. Liquid-phase peptide synthesis remains useful for particular peptide structures and manufacturing requirements, while hybrid approaches combine the benefits of different techniques. Continued improvements in automation, reaction efficiency, and purification are helping researchers select methods that match their specific project requirements.
By application, peptide synthesis is used in therapeutic development, drug discovery, diagnostics, vaccine research, and academic studies. Pharmaceutical and biotechnology companies use synthesized peptides to investigate biological targets and evaluate potential treatments. Diagnostic researchers apply peptides to develop assays and study disease-related biomarkers. Academic and research institutions use these compounds to examine protein interactions, cellular processes, and molecular pathways. In terms of end users, the market serves pharmaceutical companies, biotechnology companies, contract research organizations, and academic and research institutes.